ROKIT Healthcare Inc. (KOSDAQ: A376900)
Health Care · Biotechnology · KR
₩27,750.00
-1.25% today · -8.0% 1Y
ROKIT Healthcare Inc. (KOSDAQ: A376900) operates in the Biotechnology industry within the Health Care sector. The company is valued at $357.79M.
Over the last twelve months the share price has lost 8.0%, trading between 24.20K and 153.80K.
Tweenvest scores ROKIT Healthcare Inc. across four factors: quality 35/100, value 41/100, growth 100/100. Its strongest factor is growth.
A376900 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $357.79M
- Revenue (TTM)
- $21.19M
- P/E
- —
- EPS
- -812.68
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩153,800.00
- 52-week low
- ₩24,200.00
- Avg volume (3M)
- —
- Shares outstanding
- 17.36M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Inhibikase Therapeutics, Inc.NasdaqCM: IKT | $364.15M | $1.94 | -3.00% |
| Emergent BioSolutions Inc.NYSE: EBS | $362.50M | $7.07 | +1.73% |
| Enanta Pharmaceuticals, Inc.NasdaqGS: ENTA | $360.28M | $12.37 | +1.64% |
| ProKidney Corp.NasdaqCM: PROK | $359.35M | $1.57 | -8.72% |
| Fennec Pharmaceuticals Inc.NasdaqCM: FENC | $357.69M | $10.36 | +1.57% |
| Cuorips Inc.TSE: 4894 | $352.47M | ¥6,260.00 | +5.56% |
| BioNote, Inc.KOSE: A377740 | $352.17M | ₩4,700.00 | +1.18% |
| PureTech Health plcLSE: PRTC | $349.68M | £1.09 | +1.30% |
Figures last refreshed Oct 4, 2026.